References
- Silverman S Jr. Demographics and occurrence of oral and oropharyngeal cancers. The outcomes, the trends, the challenge. J. Am. Dent. Assoc.132(1), 7S–11S (2001).
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J. Clin.55(2), 74–108 (2005).
- Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer80(6), 827–841 (1999).
- Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol.45(4–5), 309–316 (2009).
- Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinomas: an analysis of 703 cases in southern Taiwan. Oral Oncol.35(2), 173–179 (1999).
- Zhang X, Li C, Liao Q, Reichart PA. Areca chewing in Xiangtan, Hunan province, China: interviews with chewers. J. Oral Pathol. Med.37(7), 423–429 (2008).
- Reichart PA, Nguyen XH. Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J. Oral Pathol. Med.37(9), 511–514 (2008).
- Diaz EM Jr, Holsinger C, Zuniga ER, Roberts DB, Sorensen D. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck25(4), 267–273 (2003).
- Sankaranarayanan R, Black RJ, Parkin DM. Cancer Survival in Developing Countries. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publication No. 145 (1998).
- Rogers SN, Brown JS, Woolgar JA et al. Survival following primary surgery for oral cancer. Oral Oncol.45(3), 201–211 (2009).
- Harker GJ, Stephens FO. Comparison of intra-arterial versus intravenous 5-fluorouracil administration on epidermal squamous cell carcinoma in sheep. Eur. J. Cancer28A(8–9), 1437–1441 (1992).
- Steidler NE, Reade PC. Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinoline-1-oxide. Oral Surg.57(5), 524–531 (1984).
- Nauta JM, Roodenburg JL, Nikkels PG, Witjes MJ, Vermey A. Comparison of epithelial dysplasia – the 4NQO rat palate model and human oral mucosa. Int. J. Oral Maxillofac. Surg.24(1 Pt 1), 53–58 (1995).
- Salley JJ. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J. Dent. Res.33(2), 253–262 (1954).
- Sano D, Myers JN. Xenograft models of head and neck cancers. Head Neck Oncol.1(1), 32 (2009).
- Morris AL. Factors influencing experimental carcinogenesis in the hamster cheek pouch. J. Dent. Res.40(1), 3–15 (1961).
- Lin LM, Chen YK, Chen CH, Chen YW, Huang AH, Wang WC. VX2-induced rabbit buccal carcinoma: a potential cancer model for human buccal mucosa squamous cell carcinoma. Oral Oncol.45(11), e196–e203 (2009).
- Levy BM, Gorlin R, Gottsegen R. A histologic study of the reaction of skin and mucous membrane to a single application of 9,10 dimethyl-1,2,benzanthracene. J. Dent. Res.29(5), 678–679 (1950).
- Dipple A, Piggot M, Moschel RC, Constantino N. Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res.43(9), 4132–4135 (1983).
- Shklar G, Eisenberg E, Flynn E. Immunoenhancing agents and experimental leukoplakia and carcinoma of the hamster buccal pouch. Prog. Exp. Tumor Res.24, 269–282 (1979).
- Dipple A, Pigott MA, Bigger AH, Blake DM. 7,12-dimethylbenz(a)anthracene-DNA binding in mouse skin: response of different mouse strains and effects of various modifiers of carcinogenesis. Carcinogenesis5(8), 1087–1090 (1984).
- Bigger CAH, Sawicki JT, Blake DM, Raymond LG, Dipple A. Products of binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse skin. Cancer Res.43(12 Pt 1), 5647–5651 (1983).
- Daniel FB, Joyce NJ. DNA adduct formation by 7,12-dimethylbenz(a)anthracene and its noncarcinogenic 2 linoni analogue in female Sprague–Dawley rats. J. Natl Cancer Inst.70(1), 111–118 (1983).
- Joyce NJ, Daniel FB. 7,12-dimethylbenz(a)anthracene deoxyribonucleoside adduct formation in vivo: evidence for the formation and binding of a mono-hydroxy-methyl-DMBA metabolite to rat liver in DNA. Carcinogenesis3(3), 297–301 (1982).
- Nagini S, Letchoumy PV, Thangavelu A, Ramachandran CR. Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol.45(6), e31–e37 (2009).
- Heber EM, Aromando RF, Trivillin VA et al. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model. Arch. Oral Biol.52(3), 273–279 (2007).
- Vairaktaris E, Spyridonidou S, Papakosta V et al. The hamster model of sequential oral oncogenesis. Oral Oncol.44(4), 315–324 (2008).
- Berta GN, Salamone P, Sprio AE et al. Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-β-cyclodextrin. Oral Oncol.46(1), 42–48 (2010).
- Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic progression model of oral cancer: current evidence and clinical implications. J. Oral Pathol. Med.33(6), 317–322 (2004).
- Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicenter origin. Cancer6(5), 963–968 (1953).
- Lin LM, Chen YK, Lai DR, Huang YL. Minimal arecaidine concentrations showing a promotion effect during DMBA-induced hamster cheek pouch carcinogenesis. J. Oral Pathol. Med.25(2), 65–68 (1996).
- Lin LM, Chen YK, Lai DR, Huang YL, Chen HR. Cancer-promoting effect of Taiwan betel-quid in hamster buccal pouch carcinogenesis. Oral Dis.3(4), 232–235 (1997).
- Lin LM, Chen YK, Lai DR, Huang YL, Chen HR. Cancer promoting effect of 12-O-tetradecanoylphorbol-13-acetate and collagenase in hamster buccal pouch carcinogenesis. Chin. Dent. J.16(3), 148–155 (1997).
- Lin CC, Chen YK, Lin LM. Placental glutathione S-transferase isoenzyme expression during promotion of two-stage hamster cheek-pouch carcinogenesis. Arch. Oral Biol.44(6), 525–529 (1999).
- Chen YK, Lin LM. Placental glutathione S-transferase isoenzyme expression in polycyclic aromatic hydrocarbon-induced hamster buccal pouch mucosa. Oral Oncol.34(3), 180–185 (1998).
- Lin LM, Chen YK. Creatine kinase isoenzymes activity in serum and buccal pouch tissue of hamsters during DMBA-induced squamous cell carcinogenesis. J. Oral. Pathol. Med.20(10), 479–485 (1991).
- Chen YK, Lin LM. Sequential expression of placental glutathione S-transferase isoenzyme (GST-P) during DMBA-induced hamster buccal pouch squamous cell carcinogenesis. J. Oral Pathol. Med.25(7), 388–394 (1996).
- Chen YK, Lin LM, Hsue SS, Lin DT. The mRNA expression of placental glutathione S-transferase isoenzyme in hamster buccal-pouch carcinomas using reverse transcription-polymerase chain reaction. Oral Oncol.38(2), 158–163 (2002).
- Lin LM, Chen YK. Diurnal variation of γ-glutamyl transpeptidase activity during DMBA-induced hamster buccal pouch carcinogenesis. Oral Dis.3(3), 153–156 (1997).
- Chen YK, Lin LM. Immunohistochemical expression of inducible nitric oxide synthase in DMBA-induced hamster buccal pouch carcinogenesis. Oral Oncol.36(3), 221–224 (2000).
- Chen YK, Hsue SS, Lin LM. The mRNA expression of inducible nitric oxide synthase in DMBA-induced hamster buccal-pouch carcinomas using reverse transcription-polymerase chain reaction. J. Oral Pathol. Med.31(2), 82–86 (2002).
- Chen YK, Hsue SS, Lin LM. The mRNA expression of inducible nitric oxide synthase in DMBA-induced hamster buccal-pouch carcinomas: an in situ RT-PCR study. Int. J. Exp. Pathol.83(3), 133–137 (2002).
- Chen YK, Hsue SS, Lin LM. Correlation between inducible nitric oxide synthase and p53 expression for DMBA-induced hamster buccal-pouch carcinomas. Oral Dis.9(5), 227–234 (2003).
- Lin LM, Chen YK, Huang YL, Mostofi R, Toto PD. Cytokeratins in hamster cheek pouch epithelium during DMBA induced carcinogenesis. J. Oral Pathol. Med.18(5), 280–287 (1989).
- Chen YK, Hsue SS, Lin LM. Immunohistochemical demonstration of p73 protein in the early stages of DMBA-induced hamster buccal-pouch squamous cell carcinogenesis. Arch. Oral Biol.47(9), 695–699 (2002).
- Chen YK, Hsue SS, Lin LM. Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis. Oral Dis.9(5), 235–240 (2003).
- Chen YK, Hsue SS, Lin LM. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Int. J. Exp. Pathol.85(2), 97–104 (2004).
- Hsue SS, Chen YK, Lin LM. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesisis is associated with p53 accumulation. Oral Oncol.44(1), 43–49 (2008).
- Hsue SS, Wang WC, Chen YK, Lin LM. Expression of inhibitors of apoptosis family protein in dimethyl[a]anthrance-induced hamster buccal-pouch squamous-cell carcinogenesis is associated with mutant p53 accumulation and epigenetic changes. Int. J. Exp. Pathol.89(5), 309–320 (2008).
- Reibel J, Wallenius K, Dabelsteen E. Blood group antigen staining pattern during experimental carcinogenesis in rat palate. Acta. Pathol. Microbiol. Immunol. Scand.96(2), 161–167 (1988).
- Gao S, Worm J, Guldberg P et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int. J. Cancer109(2), 230–237 (2004).
- Jin YT, Lin LM. Lectin binding patterns in squamous epithelium in experimentally induced hamster buccal pouch carcinoma. J. Oral Pathol. Med.18(8), 446–450 (1989).
- Chen YK, Hsue SS, Lin LM. Inhibitory effect of inducible nitric oxide synthase inhibitors on DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis. Nitric Oxide13(4), 232–239 (2005).
- Wang WC, Liang SL, Chen YK, Lin LM. The therapeutic effect of fractionated radiation on DMBA-induced hamster buccal pouch squamous cell carcinomas. Oral Oncol.44(12), 1160–1166 (2008).
- Zhou ZT, Jiang WW. Cancer stem cell model in oral squamous cell carcinoma. Curr. Stem Cell Res. Ther.3(1), 17–20 (2008).
- Califano J, van der Riet P, Westra W et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res.56(11), 2488–2492 (1996).
- Huang AH, Chen YK, Chan AW, Shieh TY, Lin LM. Isolation and characterization of normal hamster buccal pouch stem/stromal cells – a potential oral cancer stem/stem-like cell model. Oral Oncol.45(11), e189–e195 (2009).
- Lin MH, Hsieh SC, Li SY et al. Sequential cytogenetic alterations in hamster oral keratinocytes during DMBA-induced oral carcinogenesis. Eur. J. Cancer B. Oral Oncol.30B(4), 252–264 (1994).
- Mognetti B, Di Carlo F, Berta GN. Animal models in oral cancer research. Oral Oncol.42(5), 448–460 (2006).
- Gimenez-Conti IB, Slaga TJ. The hamster cheek pouch carcinogenesis model. J. Cell Biochem.17F(Suppl.), 83–90 (1993).
- Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J. Dent. Res.88(4), 300–306 (2009).
- Shope RE, Hurst EW. Infectious papillomatosis of rabbits: with a note on the histopathology. J. Exp. Med.58(5), 607–624 (1933).
- Kidd JG, Beard JW, Rous P. Serological reactions with a virus causing rabbit papillomas which become cancerous: II. Tests of the blood of animals carrying various epithelial tumors. J. Exp. Med.64(1), 79–96 (1936).
- Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus induced papilloma and containing the virus in a masked or altered form. J. Exp. Med.71(6), 813–838 (1940).
- Stewart HL, Snell KC, Dunham LJ, Schlyen SM. V2 carcinoma, rabbit. In: Atlas of Tumor Pathology, Transplantable and Transmissible Tumors of Animals. Armed Forces Institute of Pathology, Washington DC, USA, 38–42 (1995).
- Galasko CS, Haynes DW. Survival of VX2 carcinoma cells in vitro.Eur. J. Cancer12(12), 1025–1026 (1976).
- Shah SA, Dickson JA. Effects of hyperthermia on the immunocompetence of VX2 tumor-bearing rabbits. Cancer Res.38(10), 3523–3531 (1978).
- Easty DM, Easty GC. Establishment of an in vitro cell line from the rabbit VX2 carcinoma. Virchows Arch. B. (Cell Pathol.)39(3), 333–337 (1982).
- Herman PG, Kim CS, DeSousa MA, Mellins HZ. Microcirculation of the lymph node with metastases. Am. J. Pathol.85(2), 333–341 (1976).
- Tromberg BJ, Orenstein A, Kime S et al.In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol.52(2), 375–385 (1990).
- Conlon KC, Bading JR, McDermott EW, Corbally MT, Tolvo AJ, Brennan MF. Extremity metabolism in the cachectic, VX-2 carcinoma-bearing rabbit. J. Surg. Res.55(3), 330–337 (1993).
- Wagner S. Benign lymph node hyperplasia and lymph node metastasis in rabbits. Animal models for magnetic resonance lymphography. Invest. Radiol.29(3), 364–371 (1994).
- Harima Y, Harima K, Hasegawa T, Shikata N, Tanaka Y. Histopathological changes in rabbit uterus carcinoma after transcatheter arterial embolization using cisplatin. Cancer Chemother. Pharmacol.38(4), 317–322 (1996).
- Matsumoto K, Ninomiya Y, Inoue M, Tomioka T. Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue. Int. J. Oral Maxillofac. Surg.28(2), 118–124 (1999).
- Tamargo RJ, Bok RA, Brem H. Angiogenesis inhibition by minocycline. Cancer Res.51(2), 672–675 (1991).
- Brem H, Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J. Exp. Med.141(2), 427–439 (1975).
- Gadeholt-Göthlin G, Göthlin JH. Comparison of nephrectomy and/or doxorubicin treatment in rabbit renal VX-2 carcinoma. J. Surg. Oncol.58(2), 134–145 (1995).
- van Es RJ, Dullens HF, van der Bilt A, Koole R, Slootweg PJ. Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J. Craniomaxillofac. Surg.28(5), 300–307 (2000).
- Jefferis AF, Berenbaum MC. The rabbit VX2 tumor a model for carcinomas of the tongue and larynx. Acta Otolaryngol.108(1–2), 152–160 (1989).
- van Es RJ, Franssen O, Dullens HF et al. The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres. Lab. Anim.33(2), 1175–1184 (1999).
- Chikui T, Yuasa K, Maemura S, Kanda S. Change of angiostructure and hemodynamics in lymph node metastases in rabbits. Oral Surg. Oral Med.Oral Pathol. Oral Radiol. Endod.93(3), 350–357 (2002).
- Taniguchi K, Okamura K, Kitamura K, Honda T. Changes in nerve fibers adjacent to transplanted VX2 carcinoma in rabbit tongue. J. Oral Pathol. Med.24(1), 37–41 (1995).
- Shen N, Wu H, Xu X et al. Cervical lymph node metastasis model of pyriform sinus carcinoma. ORL J. Otorhinolaryngol. Relat. Spec.71(3), 129–134 (2009).
- Wu H, Xu X, Ying H et al. Preliminary study of indirect CT lymphography-guided sentinel lymph node biopsy in a tongue VX2 carcinoma model. Int. J. Oral Maxillofac. Surg.38(12), 1268–1272 (2009).
- Liu B, Podack ER, Allison JP, Malek TR. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J. Immunol.156(3), 1117–1125 (1996).
- Wolf GT, Schmaltz S, Hudson J et al. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis. Arch. Otolaryngol. Head Neck Surg.113(11), 1200–1206 (1987).
- Van Es RJ, Baselmans AH, Koten JW, Van Dijk JE, Koole R, Den Otter W. Perilesional IL-2 treatment of a VX2 head-and-neck cancer model can induce a systemic anti-tumour activity. Anticancer Res.20(6B), 4163–4170 (2000).
- Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol.29(Suppl. 16), 15–18 (2002).
- Horak E, Leek R, Klenk N, Lejeune S. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet340(8828), 1120–1124 (1992).
- Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet340(8812), 145–146 (1992).
- Takagi S, Inenaga R, Oya R, Nakamura S, Ikemura K. Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx. Br. J. Cancer94(11), 1580–1585 (2006).
- Gaya AM, Rustin GJS. Vascular disrupting agents: a new class of drug in cancer therapy. Clin. Oncol.17(4), 277–290 (2005).
- Folkman J. Angiogenesis. Annu. Rev. Med.57, 1–18 (2006).
- Folkman J. Antiangiogenesis in cancer therapy – endostatin and its mechanisms of action. Exp. Cell Res.312(5), 594–607 (2006).
- Wang H, Zheng LF, Feng Y et al. A comparison of 3D-CTA and 4D-CE-MRA for the dynamic monitoring of angiogenesis in a rabbit VX2 tumor. Eur. J. Radiol. DOI: 10.1016/j.ejrad.2010.03.022 (2010) (Epub ahead of print).
- Zhang K, Shi B, Chen J et al. Bone marrow mesenchymal stem cells induce angiogenesis and promote bladder cancer growth in a rabbit model. Urol. Int.84(1), 94–99 (2010).
- Kang J, Wu X, Wang Z et al. Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors. J. Ultrasound Med.29(1), 61–70 (2010).
- Shafirstein G, Kaufmann Y, Hennings L et al. Conductive interstitial thermal therapy (CITT) inhibits recurrence and metastasis in rabbit VX2 carcinoma model. Int. J. Hyperthermia25(6), 446–454 (2009).
- Xiao H, Liao Q, Cheng M et al. 5-amino-4-oxopentanoic acid photodynamic diagnosis guided microsurgery and photodynamic therapy on VX2 brain tumour implanted in a rabbit model. Chin. Med. J.122(11), 1316–1321 (2009).
- Luo W, Zhou X, Zheng X et al. Role of sonography for implantation and sequential evaluation of a VX2 rabbit liver tumor model. J. Ultrasound Med.29(1), 51–60 (2010).
- Choi SH, Kim KH, Moon WK et al. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model. J. Magn. Reson. Imaging31(1), 134–141 (2010).
- Liang XM, Tang GY, Cheng YS, Zhou B. Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging. World J. Gastroenterol.15(17), 2139–2144 (2009).
- Liu P, Huang G, Dong S, Wan L. Kinetic analysis of experimental rabbit tumour and inflammation model with 18F-FDG PET/CT. Nuklearmedizin48(4), 153–158 (2009).
- Walker F, Carter J, Crawford GP, Laird H, Lessells AM, Pollet JE. Hamster cheek pouch mucosubstances and immunological privilege. Br. J. Exp. Pathol.51(4), 379–384 (1970).